Class Actions Lawsuits
Product Liability

Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action

Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action — Product Liability class action lawsuit

Case Overview

This class action litigation involves claims that GLP-1 receptor agonist drugs, including Ozempic and Wegovy manufactured by Novo Nordisk, are associated with non-arteritic anterior ischemic optic neuropathy (NAION), a condition characterized by sudden vision loss. Plaintiffs allege that the manufacturers failed to adequately warn consumers and healthcare providers about the risk of vision loss linked to these weight loss medications.

The lawsuit seeks compensation for individuals who have suffered vision loss or other serious complications after using these drugs. The case is currently being investigated and pursued by Weitz & Luxenberg, a nationwide mass torts law firm with offices in New York, New Jersey, Los Angeles, and Detroit. Eligible parties may include anyone who used Ozempic, Wegovy, or similar GLP-1 drugs and subsequently developed vision loss or NAION.

Who May Qualify

Individuals who took Ozempic, Wegovy, or other GLP-1 receptor agonist drugs and subsequently developed vision loss or non-arteritic anterior ischemic optic neuropathy (NAION)

Frequently Asked Questions

What is NAION and how is it connected to Ozempic?

NAION (non-arteritic anterior ischemic optic neuropathy) is a condition causing sudden vision loss. The lawsuit alleges that GLP-1 drugs like Ozempic and Wegovy increase the risk of developing NAION, and that manufacturers failed to adequately warn users about this potential side effect.

Am I eligible to join the Ozempic vision loss lawsuit?

You may be eligible if you used Ozempic, Wegovy, or similar GLP-1 drugs and subsequently experienced vision loss or were diagnosed with NAION. Contact a lawyer at Weitz & Luxenberg for a free case evaluation to determine your eligibility.

Can I sue for vision loss caused by these weight loss drugs?

Yes, ongoing class action litigation is being pursued against the manufacturers of these drugs. If you suffered vision loss after using these medications, you may have legal options to seek compensation for your injuries and medical expenses.

Related Cases

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) Mass Tort Litigation — Product Liability class action lawsuit

Depo-Provera (Medroxyprogesterone) Brain Tumor (Meningioma) Mass Tort Litigation

Current
Product Liability
Women who received long-term Depo-Provera (injectable contraceptive) injections are suing Pfizer, alleging the drug significantly increases the risk of developing meningioma brain tumors and that the company failed to warn patients and physicians of this risk despite knowing about it for years.
View Details
Tesla Cybertruck Recall & Products Liability Class Action — Product Liability class action lawsuit

Tesla Cybertruck Recall & Products Liability Class Action

Current
Product Liability
Tesla Cybertruck owners filed a class action alleging that the vehicle suffers from dangerous defects — including an accelerator pedal that can get physically trapped and cause unintended full-throttle acceleration — that Tesla knew about before delivery but failed to disclose. The lawsuit follows multiple NHTSA investigations and a major safety recall.
View Details
Social Media Addiction & Youth Mental Health School District MDL — Product Liability class action lawsuit

Social Media Addiction & Youth Mental Health School District MDL

Current
Product Liability
Hundreds of school districts and personal injury plaintiffs allege that Meta, Snap, TikTok, and YouTube deliberately designed their platforms to be addictive to children and teenagers, causing a nationwide youth mental health crisis resulting in anxiety, depression, self-harm, eating disorders, and suicide.
View Details